Who
Tessa Cigler
Director
Company insider
Files Form 4 as: Director, Atossa Therapeutics.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Mar 2024
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | ATOS Atossa TherapeuticsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | ATOS Atossa TherapeuticsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | ATOS Atossa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 27 Jun 2024filed 1 Jul 2024 | ATOS Atossa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 9 Mar 2024filed 14 Mar 2024 | ATOS Atossa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,834 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.